 BNET | A Glass Half Full: Avandia Case Reveals Hole in FDA's Conflict-of-Interest Rules BNET ... or that she has given talks sponsored by AstraZeneca (maker of Seroquel), and has been a consultant for Shire (maker of Adderall XR and Vyvanse). and more » |
Shire Says FDA Approves ADHD Patch For Teens Ages 13-17 FOXBusiness ... and US Attorney for the Eastern District of Pennsylvania asked for documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. ... and more » |
Shire Says FDA Approves ADHD Patch For Teens Ages 13-17 Capital.gr (press release) ... and US Attorney for the Eastern District of Pennsylvania asked for documents related to the sales and marketing of Adderall XR, Daytrana and Vyvanse. ... and more » |
Global ADHD Therapeutics Market to Reach $4.2 Billion by 2015, According to ... Behavioral Health Central (blog) Shire Pharmaceuticals is the largest player in the ADHD market with its strong portfolio of drugs including Adderall XR, Vyvanse, Daytrana and Intuniv. ... and more » |
Global ADHD Therapeutics Market to Reach $4.2 Billion by 2015, According to ... PR Web (press release) Shire Pharmaceuticals is the largest player in the ADHD market with its strong portfolio of drugs including Adderall XR, Vyvanse, Daytrana and Intuniv. ... and more » |